At the same time, individual treatment of TRAIL and TNFα in MCF7 and MDA-MB-231 cell lines displayed an increase in 10–50% of fluorescent intensity in both breast cancer cell lines. This evidence concerns the gene TNFSF10 and breast carcinoma.